Literature DB >> 16009857

Incorporating the results of the Ocular Hypertension Treatment Study into clinical practice.

Michael A Kass, Mae O Gordon, Steven M Kymes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16009857     DOI： 10.1001/archopht.123.7.1021-b

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN： 0003-9950


× No keyword cloud information.
  4 in total

Review 1.  Role of the Rho GTPase/Rho kinase signaling pathway in pathogenesis and treatment of glaucoma: Bench to bedside research.

Authors:  Ponugoti Vasantha Rao; Padmanabhan P Pattabiraman; Casey Kopczynski
Journal:  Exp Eye Res       Date:  2016-09-01       Impact factor: 3.467

2.  Baseline mean deviation and rates of visual field change in treated glaucoma patients.

Authors:  I Forchheimer; C G de Moraes; C C Teng; F Folgar; C Tello; R Ritch; J M Liebmann
Journal:  Eye (Lond)       Date:  2011-03-11       Impact factor: 3.775

3.  Risk factors and long term progression in open angle glaucoma patients.

Authors:  Anca Delia Pantalon; Crenguţa Feraru; Dorin Chiseliţă
Journal:  Rom J Ophthalmol       Date:  2016 Jul-Sep

4.  Chemo-informatics guided study of natural inhibitors targeting rho GTPase: a lead for treatment of glaucoma.

Authors:  Sumit Kumar Rai; Rajesh Kumar Pathak; Dev Bukhsh Singh; Arun Bhatt; Mamta Baunthiyal
Journal:  In Silico Pharmacol       Date:  2021-01-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.